Manifold Bio

Manifold is on the ground at this week’s joint Keystone meetings in beautiful Keystone, Colorado. Details on our Keystone line-up: Tuesday, February 18, 2025, 19:30-22:00 (MST)? ? Poster number 1520 - Rapid Discovery and Development of Novel Brain Shuttles for Multiple “Portals” Using Multiplexed In Vivo Screening? Hala Haddad, Scientist, Manifold Bio?? Meeting: Drug Delivery to the Brain: Emerging Modalities Thursday, February 20, 2025, 14:30-16:30 (MST) ? Short talk (Longs Peak) - Rapid Discovery and Development of Novel Brain Shuttles for Multiple “Portals” Using Multiplexed In Vivo Screening? Kimberly Scearce-Levie, CSO, Manifold Bio?? Meeting: Drug Delivery to the Brain: Emerging Modalities? Symposia Spotlight 2: Emerging Modalities and Future Opportunities in Targeted Brain Delivery? ? Thursday, February 20, 2025, 14:30-16:30 (MST) ? Short talk (Grays Peak) - Integrating High-Throughput In Vivo Screening with AI-guided Protein Design to Select Brain Shuttles with Optimal Pharmacokinetics, Biodistribution, and Other Drug-like Properties? Karen Duffy, Principal Scientist, Manifold Bio? Meeting: Antibodies as Drugs: Innovative Formats, Design and Engineering? Symposia Spotlight 2: Leveraging AI and ML in Antibody Discovery, Engineering and Beyond Sean Michael Carroll will also be on the ground to chat about Manifold and meet potential collaborators. Please reach out to [email protected] to connect!??

Exciting week ahead at Keystone! Manifold Bio’s Principal Scientist, Karen Duffy, PhD, will be taking the stage this Thursday in the Symposia Spotlight: Antibodies as Drugs: Innovative Formats, Design and Engineering. Don’t miss this opportunity to hear cutting-edge insights! Learn more: https://lnkd.in/eJ9qMFcW #KSBrainDrugs25 #KeystoneSymposia #ScientificResearch

Our busy year continues with two talks and a poster at next week’s joint Keystone meetings. Manifold’s new Chief Scientific Officer,?Kimberly Scearce-Levie, will give a short talk on Thursday in the Symposia Spotlight: Emerging Modalities and Future Opportunities in Targeted Brain Delivery https://lnkd.in/eJ9qMFcW?#KSBrainDrugs25 #KeystoneSymposia #ScientificResearch

Big year ahead for Manifold’s brain shuttled medicine programs and in vivo multiplexing + AI platform. Next week Manifold Bio is headed to San Francisco for both the J.P. Morgan Healthcare Conference and the 8th Annual Sachs Neuroscience Innovation Forum to share exciting updates on our platform, programs, and personnel Our attendees include: Gleb Kuznetsov, Co-Founder & CEO Pierce Ogden, Co-Founder & CTO (new!) Kimberly Scearce-Levie, CSO Shane Lofgren, Co-Founder & Head of Portfolio Strategy We will be meeting with potential partners and investors around these events and would love to chat. Please email [email protected] to connect! #Sachs_NIF? #JPM2025

We are excited to share that our CEO, Gleb Kuznetsov, will be giving a company overview presentation at #BIO2024 in San Diego on Wednesday at 4:45pm PT. Be sure to join us for this special event!

Join us at the PEGS Summit in Boston this week! Manifold’s CSO and co-founder Pierce Ogden will share the latest on Manifold’s multiplexed in vivo protein design platform and our work on brain-shuttled biologics. Day 3 - May 15 at 3:30pm. ?? #PEGSummit #PEGS2024 #Innovation #Biotech

Manifold Bio is proud to announce our poster presentation at the American Academy of Neurology’s Annual Meeting! Join us in celebrating this milestone as our colleague, Shane Lofgren, shares groundbreaking insights and innovations from our team. Don't miss this opportunity to connect and explore the latest in neuroscience!? #AANAM #Neuroscience #Innovation #AANmember